| Downgrades | Hold Sell | X | ||
| Downgrades | Outperform Mkt Perform | X | ||
| Downgrades | Buy Hold | X | ||
| Initiated | Market Perform | X | ||
| Downgrades | Outperform Neutral | X | ||
|
$413 $349 |
||||
| Initiated | Buy | X | ||
| Downgrades | Buy Neutral | X | ||
|
$420 $350 |
||||
| Downgrades | Buy Hold | X | ||
|
$415 $345 |
||||
| Initiated | Hold | X | ||
| Initiated | Buy | X | ||
| Initiated | Buy | X | ||
| Upgrades | Hold Buy | X | ||
|
$340 $450 |
||||
| Initiated | Hold | X | ||
| Upgrades | Neutral Buy | X | ||
|
$282 $452 |
||||
| Upgrades | Neutral Outperform | X | ||
|
$270 $289 |
||||
| Upgrades | Neutral Buy | X | ||
| Upgrades | Sell Neutral | X | ||
|
$142 $238 |
||||
| Initiated | Sell | X | ||
| Initiated | Neutral | X | ||
| Upgrades | Hold Buy | X | ||
| Initiated | Hold | X | ||
| Upgrades | Mkt Perform Outperform | X | ||
MEDP Medpace Holdings, Inc.
Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ
Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
